[
    "{\"step_by_step_thinking\": \"The patient's condition indicates that she has developed neutropenia, a common side effect of chemotherapy, characterized by a decrease in the number of neutrophils in the blood. This makes her more susceptible to bacterial infections and sepsis. The drug of choice to stimulate the production of neutrophils in the bone marrow and thereby increase the neutrophil count in the blood is a granulocyte colony-stimulating factor (G-CSF). Filgrastim is a G-CSF. Darbepoetin is used to treat anemia, not neutropenia. Dexamethasone is a corticosteroid, not typically used to treat neutropenia. Interferon alfa is used to treat certain viral infections and cancers, not neutropenia.\", \"answer_choice\": \"C\"}"
]